Applied Materials stock price dips despite Needham’s big target hike — here’s what traders watch next

Applied Materials stock price dips despite Needham’s big target hike — here’s what traders watch next

New York, Jan 20, 2026, 18:54 ET — After-hours

  • Applied Materials dropped roughly 2.7% Tuesday, tracking the wider market decline.
  • A Needham analyst raised his price target to $390, pointing to stronger demand indicators.
  • Next week’s earnings from chip-equipment makers might shape the sector’s trajectory.

Applied Materials shares dropped 2.7% to $318.23 on Tuesday, then held steady in after-hours trading.

The drop is significant since the stock remains close to recent peaks following a strong January rally, leaving limited buffer for negative surprises. The sell-off coincided with a risk-off day on Wall Street, where the S&P 500 fell 2.06%, as investors rushed to offload popular semiconductor positions. 1

Applied’s shares fluctuated from $314.58 up to $324.35, with roughly 9.4 million shares changing hands throughout the session.

The broader chip sector also lost ground. The iShares Semiconductor ETF dropped roughly 1.5%, and the VanEck Semiconductor ETF dipped around 2.5%. Individual names showed uneven moves — KLA tumbled 5.3%, while Lam Research edged down just 0.2%.

The pullback happened despite Needham’s Charles Shi boosting his price target on Applied from $260 to $390, maintaining a “Strong Buy” rating. Shi cited what he described as “broad-based” demand gains over the last 90 days, based on insights from the Needham Growth Conference. 2

The conference concluded last week, serving as a routine checkpoint for management teams and investors to exchange updates on order trends and spending intentions. 3

Still, a higher target hasn’t halted the tape-driven selloff. Traders are weighing whether the upbeat chatter about tool demand will quickly translate into bookings and better margins—or if the stock is just taking a breather after a solid rally.

Export rules and licensing restrictions tied to China remain a major risk, even as demand looks solid in other regions. Applied has previously cautioned that tougher U.S. sanctions might slash revenue, a factor keeping investors cautious when the stock’s valuation climbs. 4

Next week, expect new insights from the equipment sector. ASML is set to release its results on Jan. 28, a key indicator for investment in cutting-edge chip manufacturing. 5

KLA is set to release its report on Jan. 29. Investors closely watch its commentary for clues on process-control demand and how busy fabs are running. 6

Applied is gearing up for its next big event: the fiscal first-quarter earnings report, slated for Feb. 12, according to the company’s investor relations calendar. 7

Stock Market Today

Westpac share price slides after ASX rout; investors brace for next week’s WBC update

Westpac share price slides after ASX rout; investors brace for next week’s WBC update

7 February 2026
Westpac shares fell 1.2% to A$39.43 Friday as the S&P/ASX 200 dropped 2% amid broad selling. The bank is set to roll out Microsoft 365 Copilot to 35,000 staff after a pilot last year. Investors are watching for signs of loan growth and credit quality ahead of Westpac’s first-quarter update on Feb. 13. The Reserve Bank of Australia raised its cash rate to 3.85% this week.
ANZ share price fell Friday — here’s what to watch before the ASX reopens

ANZ share price fell Friday — here’s what to watch before the ASX reopens

7 February 2026
ANZ shares closed at A$37.01 on Friday, down 1.52% as the S&P/ASX 200 fell 2% and nearly $70 billion was wiped from the market. The Reserve Bank of Australia raised its cash rate by 0.25 points to 3.85%, prompting ANZ to lift variable home loan rates from Feb. 13. ANZ announced a new Salesforce-based AI CRM rollout and a board change effective Feb. 8. Investors await ANZ’s first-quarter update on Feb. 12.
RAPT Therapeutics stock jumps 64% as GSK agrees $2.2 billion takeover at $58 a share
Previous Story

RAPT Therapeutics stock jumps 64% as GSK agrees $2.2 billion takeover at $58 a share

Lumentum stock jumps 10% as Aletheia lifts target to $500 ahead of Feb. 3 earnings
Next Story

Lumentum stock jumps 10% as Aletheia lifts target to $500 ahead of Feb. 3 earnings

Go toTop